Skip to content

Zoom@SVDs: Zooming in at microvascular malfunction in Small Vessel Diseases with 7T MRI

Zoom@SVDs: Zooming in at microvascular malfunction in Small Vessel Diseases with 7T MRI - Zoom@SVDs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47570
Enrollment
90
Registered
2016-10-05
Start date
2017-03-20
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral small vessel disease

Interventions

None listed

Sponsors

Neurologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: participants must meet all of the following criteria: -For the patients only: symptomatic SVD defined as history of clinical lacunar stroke or cognitive impairment due to SVD -age over 18 -ability to provide informed consent

Exclusion criteria

Exclusion criteria: -Other major neurological or psychiatric conditions affecting the brain and interfering with the study design (e.g. multiple sclerosis, epilepsy, Parkinson*s disease) -For the controls only: history of symptomatic SVD or pronounced silent SVD on MRI -Contraindications for MRI

Design outcomes

Primary

MeasureTime frame
Measures of microvascular function at 7T MRI: - Difference in mean velocity and pulsatility index of perforator flow between patients with SVDs and healthy controls. - Difference in time course of the BOLD-fMRI signal to a visual stimulus in different cortical layers between patients with SVDs and healthy controls. - Difference in Cerebrovascular reactivity (CVR) to a hypercapnic stimulus between patients with SVDs and healthy controls.

Secondary

MeasureTime frame
Relationship between measures of microvascular function at 7T MRI and: - Severity (total burden) and location of conventional markers of SVD on 3T MRI at baseline and progression of these lesions after 2 years. - Cognitive functioning at baseline and decline in cognitive function after 2 years - blood pressure (BP) and BP variability

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)